OOIR: Observatory of International Research

Papers

(The H4-Index of Clinical Kidney Journal is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Impact of the COVID pandemic on vascular access creation for haemodialysis in 16 Spanish haemodialysis centres	549
Correction to: Accelerated versus watchful waiting strategy of kidney replacement therapy for acute kidney injury: a systematic review and meta-analysis of randomized clinical trials	119
Use of eHealth and remote patient monitoring: a tool to support home dialysis patients, with an emphasis on peritoneal dialysis	93
Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study	81
Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study	65
Machine learning models for predicting acute kidney injury: a systematic review and critical appraisal	62
Prolonged normothermic perfusion: a promising approach to kidney transplantation	62
More dissimilarities than affinities between DNAJB11-PKD and ADPKD	61
Probability of chronic kidney disease and associated risk factors in Chinese adults: a cross-sectional study of 9 million Chinese adults in the Meinian Onehealth screening survey	52
Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR	52
Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function	50
Robot-assisted kidney transplantation: an update	48
Successful treatment of calciphylaxis with vitamin K in a patient on haemodialysis	47
The use of SGLT2 inhibitors and GLP-1 receptor agonists in older patients: a debate on approaches in CKD and non-CKD populations	45
Clinically meaningful eGFR slope as a surrogate endpoint differs across CKD stages and slope evaluation periods: the CKD-JAC study	44
Donor-derived membranous nephropathy	41
The spectrum of diseases, genetic landscape and new mutation sites of hereditary cystic kidney disease	41
Association between frailty and bone health in early-stage chronic kidney disease: a study from the population-based CARTaGENE cohort	41
Can exercise improve outcomes for frail haemodialysis patients?	40
Recent advances in pathogenetic concepts and disease modeling of IgA nephropathy	40
Causal relationships between immune cell phenotypes and primary glomerular diseases: genetic evidence from bidirectional Mendelian randomization study	39
Circulating miR-129-3p in combination with clinical factors predicts vascular calcification in hemodialysis patients	38
Bilateral nephrectomy in autosomal dominant polycystic kidney disease patients before or after renal transplantation: data from a retrospective cohort study	37
Toward acid- and heparin-free dialysis: the regional anticoagulation approach	36
Obinutuzumab treatment for membranous nephropathy: effectiveness and safety concerns during the COVID-19 pandemic	36

Correction to: Recognition of intraglomerular histological features with deep learning in protocol transplant biopsies and their association with kidney function and prognosis	36
Risk factors for acute kidney injury and kidney relapse in patients with lupus podocytopathy	34
A puzzling renal Fanconi Syndrome	33
Biomarkers in clinical epidemiology studies	33
Meet and greet but avoid the heat: a reflection on the carbon footprint of congresses prompted by ERA2023	33
Risk factors for steroid-induced osteonecrosis of the femoral head in children with immune kidney disease	32
Differentiating primary and secondary FSGS using non-invasive urine biomarkers	32